ACTA1 and Hepatic fibrosis: Therefore, the current study aimed to investigate the potential antifibrotic effects of RBO against TAA-induced liver fibrosis in rats and the involvement of the TGF-β1/FAK/α-SMA pathway to TAA-induced liver fibrosis.